Acepromazine
Calcium Carbonate can cause a decrease in the absorption of Acepromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aceprometazine
Calcium Carbonate can cause a decrease in the absorption of Aceprometazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alclometasone
The bioavailability of Alclometasone can be decreased when combined with Calcium Carbonate.
Advertisement
Aldosterone
The bioavailability of Aldosterone can be decreased when combined with Calcium Carbonate.
Alendronate
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Carbonate.
Alendronic acid
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Carbonate.
Advertisement
Allopurinol
Calcium Carbonate can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Amcinonide
The bioavailability of Amcinonide can be decreased when combined with Calcium Carbonate.
Amphetamine
Calcium Carbonate may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Advertisement
Androstenedione
The bioavailability of Androstenedione can be decreased when combined with Calcium Carbonate.
Atazanavir
Calcium Carbonate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Atorvastatin
The serum concentration of Atorvastatin can be decreased when it is combined with Calcium Carbonate.
Beclomethasone Dipropionate
The bioavailability of Beclomethasone dipropionate can be decreased when combined with Calcium Carbonate.
Benzphetamine
Calcium Carbonate may decrease the excretion rate of Benzphetamine which could result in a higher serum level.
Betamethasone
The bioavailability of Betamethasone can be decreased when combined with Calcium Carbonate.
Bisacodyl
The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Calcium Carbonate.
Bismuth Subcitrate
The therapeutic efficacy of Bismuth Subcitrate can be decreased when used in combination with Calcium Carbonate.
Bosutinib
The serum concentration of Bosutinib can be decreased when it is combined with Calcium Carbonate.
Bosutinib monohydrate
The serum concentration of Bosutinib can be decreased when it is combined with Calcium Carbonate.
Budesonide
The bioavailability of Budesonide can be decreased when combined with Calcium Carbonate.
Calcium Acetate
The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Calcium Acetate.
Captopril
Calcium Carbonate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefditoren
The serum concentration of Cefditoren can be decreased when it is combined with Calcium Carbonate.
Cefpodoxime
The serum concentration of Cefpodoxime can be decreased when it is combined with Calcium Carbonate.
Ceftriaxone
The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Ceftriaxone.
Cefuroxime
The serum concentration of Cefuroxime can be decreased when it is combined with Calcium Carbonate.
Cerivastatin
The serum concentration of Cerivastatin can be decreased when it is combined with Calcium Carbonate.
Chloroquine
The serum concentration of Chloroquine can be decreased when it is combined with Calcium Carbonate.
Chlorpromazine
Calcium Carbonate can cause a decrease in the absorption of Chlorpromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Chlortetracycline
Calcium Carbonate can cause a decrease in the absorption of Chlortetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ciclesonide
The bioavailability of Ciclesonide can be decreased when combined with Calcium Carbonate.
Cinoxacin
Calcium Carbonate can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Clobetasol
The bioavailability of Clobetasol can be decreased when combined with Calcium Carbonate.
Clobetasol Propionate
The bioavailability of Clobetasol propionate can be decreased when combined with Calcium Carbonate.
Clobetasone
The bioavailability of Clobetasone can be decreased when combined with Calcium Carbonate.
Clocortolone
The bioavailability of Clocortolone can be decreased when combined with Calcium Carbonate.
Clodronic Acid
The serum concentration of Clodronic Acid can be decreased when it is combined with Calcium Carbonate.
Cortisone Acetate
The bioavailability of Cortisone acetate can be decreased when combined with Calcium Carbonate.
Cyclopenthiazide
Cyclopenthiazide may decrease the excretion rate of Calcium Carbonate which could result in a higher serum level.
Cysteamine
The therapeutic efficacy of Cysteamine can be decreased when used in combination with Calcium Carbonate.
Dabigatran Etexilate
The serum concentration of Dabigatran etexilate can be decreased when it is combined with Calcium Carbonate.
Dabrafenib
The serum concentration of Dabrafenib can be decreased when it is combined with Calcium Carbonate.
Dasatinib
Calcium Carbonate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dasatinib Anhydrous
Calcium Carbonate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deferiprone
The serum concentration of Deferiprone can be decreased when it is combined with Calcium Carbonate.
Deflazacort
The bioavailability of Deflazacort can be decreased when combined with Calcium Carbonate.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Calcium Carbonate.
Demeclocycline
Calcium Carbonate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Desonide
The bioavailability of Desonide can be decreased when combined with Calcium Carbonate.
Desoximetasone
The bioavailability of Desoximetasone can be decreased when combined with Calcium Carbonate.
Desoxycorticosterone acetate
The bioavailability of Desoxycorticosterone acetate can be decreased when combined with Calcium Carbonate.
Desoxycorticosterone Pivalate
The bioavailability of Desoxycorticosterone Pivalate can be decreased when combined with Calcium Carbonate.
Dexamethasone
The bioavailability of Dexamethasone can be decreased when combined with Calcium Carbonate.
Dexmethylphenidate
Calcium Carbonate can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Dextroamphetamine
Calcium Carbonate may decrease the excretion rate of Dextroamphetamine which could result in a higher serum level.
Dibasic potassium phosphate
Calcium Carbonate can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diethylpropion
Calcium Carbonate may decrease the excretion rate of Diethylpropion which could result in a higher serum level.
Diflorasone
The bioavailability of Diflorasone can be decreased when combined with Calcium Carbonate.
Diflucortolone
The bioavailability of Difluocortolone can be decreased when combined with Calcium Carbonate.
Difluprednate
The bioavailability of Difluprednate can be decreased when combined with Calcium Carbonate.
Dobutamine
The therapeutic efficacy of Dobutamine can be decreased when used in combination with Calcium Carbonate.
Dolutegravir
The serum concentration of Dolutegravir can be decreased when it is combined with Calcium Carbonate.
Doxycycline
Calcium Carbonate can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Doxycycline Anhydrous
Calcium Carbonate can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Eltrombopag
The serum concentration of Eltrombopag can be decreased when it is combined with Calcium Carbonate.
Elvitegravir
The serum concentration of Elvitegravir can be decreased when it is combined with Calcium Carbonate.
Enoxacin
Calcium Carbonate can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Erlotinib
The serum concentration of Erlotinib can be decreased when it is combined with Calcium Carbonate.
Estramustine
Calcium Carbonate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Estrone
The bioavailability of Estrone can be decreased when combined with Calcium Carbonate.
Etidronate
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Carbonate.
Etidronic Acid
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Carbonate.
Ferric Carboxymaltose
Calcium Carbonate can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Pyrophosphate
Calcium Carbonate can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fexofenadine
The serum concentration of Fexofenadine can be decreased when it is combined with Calcium Carbonate.
Fleroxacin
Calcium Carbonate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fludrocortisone
The bioavailability of Fludrocortisone can be decreased when combined with Calcium Carbonate.
Flumequine
Calcium Carbonate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Flumethasone
The bioavailability of Flumethasone can be decreased when combined with Calcium Carbonate.
Flunisolide
The bioavailability of Flunisolide can be decreased when combined with Calcium Carbonate.
Flunisolide Anhydrous (obsolete)
The bioavailability of Flunisolide can be decreased when combined with Calcium Carbonate.
Fluocinolone Acetonide
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Calcium Carbonate.
Fluocinonide
The bioavailability of Fluocinonide can be decreased when combined with Calcium Carbonate.
Fluocortolone
The bioavailability of Fluocortolone can be decreased when combined with Calcium Carbonate.
Fluorometholone
The bioavailability of Fluorometholone can be decreased when combined with Calcium Carbonate.
Fluphenazine
Calcium Carbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
FLUPREDNIDENE
The bioavailability of Fluprednidene can be decreased when combined with Calcium Carbonate.
Fluprednisolone
The bioavailability of Fluprednisolone can be decreased when combined with Calcium Carbonate.
Flurandrenolide
The bioavailability of Flurandrenolide can be decreased when combined with Calcium Carbonate.
Fluticasone Furoate
The bioavailability of Fluticasone furoate can be decreased when combined with Calcium Carbonate.
Fluticasone propionate
The bioavailability of Fluticasone propionate can be decreased when combined with Calcium Carbonate.
Fluvastatin
The serum concentration of Fluvastatin can be decreased when it is combined with Calcium Carbonate.
Formestane
The bioavailability of Formestane can be decreased when combined with Calcium Carbonate.
Fosinopril
Calcium Carbonate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gabapentin
The serum concentration of Gabapentin can be decreased when it is combined with Calcium Carbonate.
Gatifloxacin
Calcium Carbonate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gatifloxacin Anhydrous
Calcium Carbonate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gefitinib
The serum concentration of Gefitinib can be decreased when it is combined with Calcium Carbonate.
Gemifloxacin
Calcium Carbonate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gemifloxacin Mesylate
Calcium Carbonate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Grepafloxacin
Calcium Carbonate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Halcinonide
The bioavailability of Halcinonide can be decreased when combined with Calcium Carbonate.
Halobetasol
The bioavailability of Ulobetasol can be decreased when combined with Calcium Carbonate.
Hydrocortisone
The bioavailability of Hydrocortisone can be decreased when combined with Calcium Carbonate.
Hyoscyamine
The serum concentration of Hyoscyamine can be decreased when it is combined with Calcium Carbonate.
Ibandronate
The serum concentration of Ibandronate can be decreased when it is combined with Calcium Carbonate.
Ibandronic Acid
The serum concentration of Ibandronate can be decreased when it is combined with Calcium Carbonate.
Iron
Calcium Carbonate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Calcium Carbonate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Sucrose
Calcium Carbonate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron-Dextran Complex
Calcium Carbonate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Isoniazid
Calcium Carbonate can cause a decrease in the absorption of Isoniazid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Itraconazole
The serum concentration of Itraconazole can be decreased when it is combined with Calcium Carbonate.
Ketoconazole
The serum concentration of Ketoconazole can be decreased when it is combined with Calcium Carbonate.
Ledipasvir
The serum concentration of Ledipasvir can be decreased when it is combined with Calcium Carbonate.
Levofloxacin
Calcium Carbonate can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levofloxacin Anhydrous
Calcium Carbonate can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levothyroxine
The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Calcium Carbonate.
Liothyronine
The therapeutic efficacy of Liothyronine can be decreased when used in combination with Calcium Carbonate.
Lisdexamfetamine
Calcium Carbonate may decrease the excretion rate of Lisdexamfetamine which could result in a higher serum level.
Lisdexamfetamine Dimesylate
Calcium Carbonate may decrease the excretion rate of Lisdexamfetamine which could result in a higher serum level.
Loteprednol
The bioavailability of Loteprednol can be decreased when combined with Calcium Carbonate.
Lovastatin
The serum concentration of Lovastatin can be decreased when it is combined with Calcium Carbonate.
Mecamylamine
The serum concentration of Mecamylamine can be increased when it is combined with Calcium Carbonate.
Medronate
The serum concentration of Technetium Tc-99m medronate can be decreased when it is combined with Calcium Carbonate.
Medrysone
The bioavailability of Medrysone can be decreased when combined with Calcium Carbonate.
Memantine
The serum concentration of Memantine can be increased when it is combined with Calcium Carbonate.
Mephentermine
Calcium Carbonate may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Mesalamine
The therapeutic efficacy of Mesalazine can be decreased when used in combination with Calcium Carbonate.
Mesoridazine
Calcium Carbonate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methamphetamine
Calcium Carbonate may decrease the excretion rate of Methamphetamine which could result in a higher serum level.
Methenamine
The therapeutic efficacy of Methenamine can be decreased when used in combination with Calcium Carbonate.
Methotrimeprazine
Calcium Carbonate can cause a decrease in the absorption of Methotrimeprazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methylene blue
Calcium Carbonate can cause a decrease in the absorption of Methylene blue resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methylphenidate
Calcium Carbonate can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Methylprednisolone
The bioavailability of Methylprednisolone can be decreased when combined with Calcium Carbonate.
Minocycline
Calcium Carbonate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Misoprostol
The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Misoprostol.
Mometasone
The bioavailability of Mometasone can be decreased when combined with Calcium Carbonate.
Moricizine
Calcium Carbonate can cause a decrease in the absorption of Moricizine resulting in a reduced serum concentration and potentially a decrease in efficacy.
MYCOPHENOLATE
Calcium Carbonate can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mycophenolic Acid
Calcium Carbonate can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nalidixic Acid
Calcium Carbonate can cause a decrease in the absorption of Nalidixic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nilotinib
The serum concentration of Nilotinib can be decreased when it is combined with Calcium Carbonate.
Norfloxacin
Calcium Carbonate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
p-Hydroxyamphetamine
Calcium Carbonate may decrease the excretion rate of Hydroxyamphetamine which could result in a higher serum level.
Pamidronate
The serum concentration of Pamidronate can be decreased when it is combined with Calcium Carbonate.
Pamidronic Acid
The serum concentration of Pamidronate can be decreased when it is combined with Calcium Carbonate.
Paramethasone
The bioavailability of Paramethasone can be decreased when combined with Calcium Carbonate.
Pazopanib
The serum concentration of Pazopanib can be decreased when it is combined with Calcium Carbonate.
Pefloxacin
Calcium Carbonate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Penicillamine
The serum concentration of Penicillamine can be decreased when it is combined with Calcium Carbonate.
Perazine
Calcium Carbonate can cause a decrease in the absorption of Perazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Periciazine
Calcium Carbonate can cause a decrease in the absorption of Propericiazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Perphenazine
Calcium Carbonate can cause a decrease in the absorption of Perphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Phentermine
Calcium Carbonate may decrease the excretion rate of Phentermine which could result in a higher serum level.
PHENTERMINE RESIN
Calcium Carbonate may decrease the excretion rate of Phentermine which could result in a higher serum level.
Pitavastatin
The serum concentration of Pitavastatin can be decreased when it is combined with Calcium Carbonate.
Polystyrene Sulfonate
The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Tolevamer.
Polystyrene Sulfonic Acid
The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Tolevamer.
Prasterone
The bioavailability of Prasterone can be decreased when combined with Calcium Carbonate.
Pravastatin
The serum concentration of Pravastatin can be decreased when it is combined with Calcium Carbonate.
Prednicarbate
The bioavailability of Prednicarbate can be decreased when combined with Calcium Carbonate.
Prednisolone
The bioavailability of Prednisolone can be decreased when combined with Calcium Carbonate.
Prednisone
The bioavailability of Prednisone can be decreased when combined with Calcium Carbonate.
Pregnenolone
The bioavailability of Pregnenolone can be decreased when combined with Calcium Carbonate.
Prochlorperazine
Calcium Carbonate can cause a decrease in the absorption of Prochlorperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Promazine
Calcium Carbonate can cause a decrease in the absorption of Promazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Promethazine
Calcium Carbonate can cause a decrease in the absorption of Promethazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Proscillaridin
Calcium Carbonate may increase the arrhythmogenic activities of Proscillaridin.
Pseudoephedrine
Calcium Carbonate may decrease the excretion rate of Pseudoephedrine which could result in a higher serum level.
Quinidine
Calcium Carbonate may decrease the excretion rate of Quinidine which could result in a higher serum level.
Quinine
The serum concentration of Quinine can be decreased when it is combined with Calcium Carbonate.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Calcium Carbonate.
Rimexolone
The bioavailability of Rimexolone can be decreased when combined with Calcium Carbonate.
Riociguat
The serum concentration of Riociguat can be decreased when it is combined with Calcium Carbonate.
Risedronate
The serum concentration of Risedronate can be decreased when it is combined with Calcium Carbonate.
Risedronic Acid
The serum concentration of Risedronate can be decreased when it is combined with Calcium Carbonate.
Rosoxacin
Calcium Carbonate can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rosuvastatin
The serum concentration of Rosuvastatin can be decreased when it is combined with Calcium Carbonate.
Simvastatin
The serum concentration of Simvastatin can be decreased when it is combined with Calcium Carbonate.
Sodium glycerophosphate
Calcium Carbonate can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SODIUM GLYCEROPHOSPHATE ANHYDROUS
Calcium Carbonate can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate
Calcium Carbonate can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate, Monobasic
Calcium Carbonate can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Calcium Carbonate can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sotalol
The serum concentration of Sotalol can be decreased when it is combined with Calcium Carbonate.
Sparfloxacin
Calcium Carbonate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sucroferric Oxyhydroxide
Calcium Carbonate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sulpiride
The serum concentration of Sulpiride can be decreased when it is combined with Calcium Carbonate.
Technetium Tc 99m Medronate
The serum concentration of Technetium Tc-99m medronate can be decreased when it is combined with Calcium Carbonate.
Temafloxacin
Calcium Carbonate can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thiethylperazine
Calcium Carbonate can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thioctic Acid
Calcium Carbonate can cause a decrease in the absorption of Lipoic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thioproperazine
Calcium Carbonate can cause a decrease in the absorption of Thioproperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thioridazine
Calcium Carbonate can cause a decrease in the absorption of Thioridazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thyroid, Porcine
The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Calcium Carbonate.
Tiludronate
The serum concentration of Tiludronic acid can be decreased when it is combined with Calcium Carbonate.
Tiludronic Acid
The serum concentration of Tiludronic acid can be decreased when it is combined with Calcium Carbonate.
Tixocortol
The bioavailability of Tixocortol can be decreased when combined with Calcium Carbonate.
Triamcinolone
The bioavailability of Triamcinolone can be decreased when combined with Calcium Carbonate.
Trientine
Calcium Carbonate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trifluoperazine
Calcium Carbonate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Triflupromazine
Calcium Carbonate can cause a decrease in the absorption of Triflupromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trimeprazine
Calcium Carbonate can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trovafloxacin
Calcium Carbonate can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zoledronic Acid
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium Carbonate.
Zoledronic Acid Anhydrous
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium Carbonate.
